US at a glance
- Population
- 341.8 million 2025
- Life expectancy at birth
- 78.9 years, 2024
- People aged 65 and over
- 18.4 % of people, 2025
- Health spending per person
- 13,473 US$ per person, 2023
- Doctors
- 3.68 per 1,000 people, 2022
US Clinical Decision Support Systems Market Industry Trends and Forecast to 2034: Segmented by (Type, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$2.80 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $2.55 Bn | — | — |
| 2025 (base) | $2.76 Bn | +$206.8 Mn | — |
| 2026 (forecast) | $2.98 Bn | +$223.6 Mn | +8.1% |
| 2027 (forecast) | $3.23 Bn | +$241.7 Mn | +16.9% |
| 2028 (forecast) | $3.49 Bn | +$261.3 Mn | +26.3% |
| 2029 (forecast) | $3.77 Bn | +$282.4 Mn | +36.6% |
| 2030 (forecast) | $4.07 Bn | +$305.3 Mn | +47.6% |
| 2031 (forecast) | $4.40 Bn | +$330.0 Mn | +59.6% |
| 2032 (forecast) | $4.76 Bn | +$356.8 Mn | +72.5% |
| 2033 (forecast) | $5.15 Bn | +$385.7 Mn | +86.5% |
| 2034 (forecast) | $5.56 Bn | +$416.9 Mn | +101.6% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Clinical decision support systems give doctors and nurses alerts, reminders and evidence-based advice inside their workflow.
Key segments of the clinical Decision Support Systems market include type (Knowledge-Based and AI-Based) and application (Drug Interaction Alerts, Diagnostics Support and Care Pathways).
Advances in machine learning and large language models, more digital health data, clinician shortages and pressure to cut costs are driving the clinical Decision Support Systems market. Health systems are moving from pilots to wider use.
Generative AI, automation of paperwork and AI tools approved as medical devices give the clinical Decision Support Systems market strong growth, including in emerging health systems.
Concerns about accuracy, bias, privacy and liability, along with unclear regulation and the cost of fitting AI into clinical workflows, hold back the clinical Decision Support Systems market.
The clinical Decision Support Systems market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the clinical Decision Support Systems market. Government digital health programs in US are speeding up adoption.
What doctors and scientists are doing in Clinical Decision Support Systems right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.
[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
From our blog
Pharmaceuticals · US
Healthcare Services · US
Healthcare Services · US
Healthcare Services · US
Healthcare Services · US
Healthcare Services · US